Leveraging HOPE’s clinical and research prowess and Diagens’ technical expertise in AI, the collaboration will encompass academic research, specialised model training, clinical translation and validation, the development of AI evaluation systems, and talent and academic exchange.
Under the MoU, the two parties will align on initial joint research projects, with a focus on medical imaging AI for maternal and child health, specialised model development, assisted diagnosis, and clinical validation. Subject to regulatory compliance, they will also explore pathways to support healthcare development across the Greater Bay Area.
